Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:8065
TSE:8065Trade Distributors

Sato Shoji (TSE:8065) Q4 EPS Jump Tests Views On Slim 2.2% Margin Sustainability

Sato Shoji (TSE:8065) has wrapped up FY 2026 with fourth quarter revenue of ¥75.6b and basic EPS of ¥102.85, against a backdrop of 9.2% earnings growth over the last 12 months and a net profit margin of 2.2%. Over recent quarters, revenue has moved from ¥69.7b in Q4 FY 2025 to ¥70.3b in Q1 FY 2026, ¥72.0b in Q2, ¥74.2b in Q3 and now ¥75.6b in Q4. Quarterly EPS has ranged from ¥73.22 to ¥102.85, while the trailing 12 month EPS reached ¥314.14. Taken together with that earnings profile and...
TSE:6877
TSE:6877Machinery

Obara Group (TSE:6877) Earnings Growth Outpaces Margins And Tests Bullish Narratives

Obara Group (TSE:6877) has just posted its Q2 2026 numbers, with revenue of ¥17.6b and basic EPS of ¥129.85, set against trailing twelve month revenue of ¥69.5b and EPS of ¥499.16 that reflects 17.1% earnings growth over the past year. Over recent quarters the company has seen revenue fluctuate between ¥13.2b and ¥18.4b while quarterly EPS has ranged from about ¥91.16 to ¥129.85, giving you a clear view of how the top line and per share earnings have tracked each other into this latest print...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

A Look At Regeneron Pharmaceuticals (REGN) Valuation After Otarmeni’s Accelerated FDA Approval

How Otarmeni’s approval fits into the Regeneron Pharmaceuticals (REGN) story The FDA’s accelerated approval of Otarmeni, the first gene therapy for genetic hearing loss that Regeneron Pharmaceuticals (REGN) plans to provide free to U.S. patients, puts patient access and ESG considerations firmly in focus for investors. For you as a shareholder or potential buyer, this move sits at the intersection of medicine, brand equity, and long term platform value. It does not point directly to near term...
NYSE:COP
NYSE:COPOil and Gas

ConocoPhillips (COP) Valuation Check After Q1 Beat And North Sea Gas Field Revival

Why ConocoPhillips Stock Is Back in Focus ConocoPhillips (COP) is drawing fresh attention after Q1 2026 earnings topped expectations, updated guidance addressed Middle East related production uncertainty, and Norway approved the company’s plan to revive long idle North Sea gas fields. See our latest analysis for ConocoPhillips. Despite the recent news flow, ConocoPhillips’ share price has cooled, with a 12.82% 1 month share price decline and an 8.67% 7 day share price decline. However, the...
NYSE:MRSH
NYSE:MRSHInsurance

Is Marsh & McLennan (MRSH) Now Offering Better Value After Its 1-Year Share Price Slump?

Investors may be wondering whether Marsh & McLennan Companies is starting to offer better value, or if the current share price already reflects its strengths. The stock last closed at US$166.03, with returns of a 1% decline over 7 days, a 3.8% decline over 30 days, a 9% decline year to date, a 25.9% decline over 1 year, and a 3.4% decline over 3 years, compared with a 33.1% gain over 5 years. Recent market attention has focused on how Marsh & McLennan Companies is positioned within the...
NYSE:CAH
NYSE:CAHHealthcare

Is It Time To Reassess Cardinal Health (CAH) After Its Multi Year Share Price Surge

For investors considering whether Cardinal Health's share price still offers value after a strong multi year run, this article explains what the current market price could be implying about the stock. The stock last closed at US$185.28, with returns of 27.2% over 1 year, 129.5% over 3 years and 270.6% over 5 years. This comes despite 7 day, 30 day and year to date returns of 3.9%, 12.9% and 9.9% declines respectively. Recent coverage around Cardinal Health has focused on its role as a major...
TSE:6023
TSE:6023Machinery

Daihatsu Infinearth Mfg Co Ltd (TSE:6023) Q4 EPS Jump Tests Slowing Growth Narrative

Daihatsu Infinearth Mfg.Co.Ltd (TSE:6023) has just closed FY 2026 with fourth quarter revenue of ¥26.9b and basic EPS of ¥87.25, rounding out a year in which trailing twelve month revenue sat at ¥88.1b and EPS at ¥232.87. Over recent quarters the company has seen revenue range from ¥19.6b to ¥26.9b, while quarterly EPS moved between ¥36.89 and ¥87.25, giving a view of how the top line and per share earnings have tracked into this latest print. With trailing net profit margins reported at...
TSE:4958
TSE:4958Chemicals

T. Hasegawa (TSE:4958) EPS Jump To ¥64.47 Tests Slow Growth Narrative

T. Hasegawa (TSE:4958) has reported Q2 2026 revenue of ¥19.8b and basic EPS of ¥64.47, with trailing twelve month revenue at ¥75.3b and EPS at ¥179.95 setting the broader backdrop for the latest quarter. The company has seen quarterly revenue move from ¥18.2b in Q2 2025 to ¥19.8b in Q2 2026, while basic EPS over the same quarters has shifted from ¥46.44 to ¥64.47. This gives investors a clearer read on how recent results sit within a slower earnings growth profile, modest revenue forecasts...
TSE:4674
TSE:4674Software

Cresco (TSE:4674) Earnings Growth Of 19.8% Tests Market Discount Narrative

Cresco (TSE:4674) closed out FY 2026 with fourth quarter revenue of ¥17.5b and basic EPS of ¥41.98, underpinned by net income of ¥1.7b. Over recent periods the company has seen revenue move from ¥15.7b and basic EPS of ¥35.84 in FY 2025 Q4 to ¥17.5b and ¥41.98 respectively in FY 2026 Q4, while trailing 12 month EPS reached ¥129.81 alongside a net profit margin of 8.2%. For investors, this combination of higher recent earnings levels and firmer margins presents the latest results as a...
TSE:4704
TSE:4704Software

Why Trend Micro (TSE:4704) Is Up 6.4% After Deepening Its Claude-Powered AI Security Collaboration

In April 2026, TrendAI™, the enterprise AI security arm of Trend Micro, announced a collaboration with Anthropic to expand use of Claude Opus 4.7 for AI-accelerated security research, combining AI-driven code intelligence with real-world risk prioritization across complex software ecosystems. This partnership, alongside TrendAI’s AESIR research platform and Vision One operational tools, positions Trend Micro directly at the intersection of AI-enabled cyber threats and AI-powered defenses,...
TSE:6222
TSE:6222Machinery

Shima Seiki Mfg.Ltd (TSE:6222) One Off ¥820m Gain Clouds Fresh Profitability Narrative

Shima Seiki Mfg.Ltd (TSE:6222) has wrapped up FY 2026 with fourth quarter revenue of ¥9.2b and basic EPS of ¥13.68, capping a year in which quarterly revenue ranged from ¥6.2b to ¥10.5b and EPS swung between a loss of ¥8.32 and a gain of ¥26.34. Across the trailing twelve months, revenue came in at ¥33.5b with basic EPS of ¥25.21. This sets the scene for investors to focus on how sustainably the latest profits have been earned and what that means for margins going forward. See our full...
NYSE:CRK
NYSE:CRKOil and Gas

Comstock Resources (CRK) Is Down 15.0% After Western Haynesville Power Hub Gas-Supply Deal Secured – Has The Bull Case Changed?

Comstock Resources, Inc. has reported past first-quarter 2026 results showing revenue of US$587.35 million, a swing to net income of US$107.45 million, and improved earnings per share alongside strong initial production from new Haynesville/Bossier shale wells. At the same time, the company accepted selection to supply natural gas for a 5.2 gigawatt Western Haynesville power hub, highlighting a major long-term demand source even as free cash flow remains under pressure from intensive...
NYSE:ESI
NYSE:ESIChemicals

A Look At Element Solutions (ESI) Valuation After Mixed First Quarter Results And Portfolio Expansion

Why Element Solutions (ESI) is in focus after its latest earnings Element Solutions (ESI) recently reported first quarter results, with sales of US$840 million versus US$593.7 million a year earlier, while net income was US$55.9 million compared with US$98 million. See our latest analysis for Element Solutions. Even with a 4.45% 1-day share price decline to US$42.27 after earnings and a modest 7-day pullback, Element Solutions still sits on a 22.17% 1-month share price return and a 100.61%...
TSE:9902
TSE:9902Trade Distributors

Nichiden (TSE:9902) Margin Compression To 3.6% Tests Bullish Earnings Growth Narrative

NICHIDEN (TSE:9902) has closed out FY 2026 with fourth quarter revenue of ¥38.2b and basic EPS of ¥57.21, supported by trailing twelve month revenue of ¥141.0b and EPS of ¥173.16, alongside earnings growth of 4.5% over the past year and 6.2% per year on average over five years. Over recent quarters the company has seen revenue move from ¥34.8b and EPS of ¥46.30 in Q4 FY 2025 to ¥38.2b and EPS of ¥57.21 in Q4 FY 2026, while the current net profit margin sits at 3.6% and leaves investors...
TSE:7971
TSE:7971Building

TOLI (TSE:7971) Margin Improvement Supports Bullish Earnings Growth Narratives

TOLI (TSE:7971) has wrapped up FY 2026 with fourth quarter revenue of ¥30.5b and basic EPS of ¥34.45, set against trailing twelve month revenue of ¥112.3b and EPS of ¥76.86 that has been paired with earnings growth of 27.1% over the past year. Over recent quarters the company has seen revenue move from ¥27.2b and EPS of ¥12.21 in Q2 FY 2026 to ¥29.5b and EPS of ¥23.93 in Q3, before reaching ¥30.5b and EPS of ¥34.45 in Q4, with net profit margin over the last 12 months sitting at 4% versus...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

What J.B. Hunt (JBHT)'s Dow Sustainability Index Addition Means For Shareholders

J.B. Hunt Transport Services was recently added to the Dow Jones Best-in-Class North America Index after S&P Global’s 2025 Corporate Sustainability Assessment, recognizing it as one of only four ground transportation companies, and the only trucking company, to qualify. This inclusion underscores how the company’s efforts to cut carbon emissions intensity and shift freight from highway to rail are gaining external validation that may matter to long-term stakeholders. Next, we’ll consider how...
NYSE:OII
NYSE:OIIEnergy Services

Assessing Oceaneering International (OII) Valuation After Strong Recent Gains And A Mixed Short Term Pullback

Recent performance snapshot and why the stock is on investors’ radar Oceaneering International (OII) has drawn attention after a mixed stretch in its share performance, with a 1 day return of a 1.3% decline and a 7 day move of a 2.6% decline as investors reassess recent gains. See our latest analysis for Oceaneering International. While the recent pullback, including a 2.4% 30 day share price return decline from the latest close of $36.58, hints at cooling short term momentum, the 47.2%...
NYSE:CRL
NYSE:CRLLife Sciences

A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum

Charles River Laboratories International (CRL) is back on investor radars after recent share price moves, with the stock near US$181 and mixed returns across the past year, the past month, and the past three months. See our latest analysis for Charles River Laboratories International. The recent 7 day share price return of 8.81% contrasts with a year to date share price return of 10.25% and a 1 year total shareholder return of 28.52%, suggesting short term momentum is picking up after a...
SEHK:3899
SEHK:3899Machinery

CIMC Enric Holdings Q1 2026 Revenue Update And What It Could Mean For Valuation

Q1 revenue update and why it matters for CIMC Enric Holdings (SEHK:3899) shareholders CIMC Enric Holdings (SEHK:3899) reported unaudited first quarter 2026 revenue of CN¥5,144 million, compared with CN¥5,765 million a year ago. This is a data point that can quickly influence how the market views the stock. See our latest analysis for CIMC Enric Holdings. The trading update comes at a time when the stock is priced at HK$10.78, with a 7 day share price return of 2.76% contrasting with a 90 day...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

A Look At 10x Genomics (TXG) Valuation After Recent Share Price Moves

How 10x Genomics Stock Has Been Trading Recently With no single headline event driving attention today, 10x Genomics (TXG) is on investors’ radar mainly because of its recent share performance. The stock has seen a 1% decline over the past day and gains over the past month. See our latest analysis for 10x Genomics. Zooming out, the recent 1-day share price decline sits against a 34.9% year to date share price return and a very large 159.79% 1-year total shareholder return, while the 5-year...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

A Look At Regencell Bioscience Holdings (RGC) Valuation After DOJ Probe And Class Action Lawsuits

What the latest half year loss means alongside the legal pressure Regencell Bioscience Holdings (NasdaqCM:RGC) has moved back into focus after reporting a half year net loss of US$5.32 million and a wider basic loss per share, while multiple securities class actions and a Department of Justice investigation continue in the background. See our latest analysis for Regencell Bioscience Holdings. The share price has been highly sensitive to headlines, with a 14.1% 1 day share price return and...
NYSE:RLJ
NYSE:RLJHotel and Resort REITs

A Look At RLJ Lodging Trust (RLJ) Valuation After Guidance Increase And $250 Million Buyback

Why RLJ Lodging Trust Stock Is Back on Investors' Radar RLJ Lodging Trust (RLJ) has drawn fresh attention after raising its unaudited 2026 net income guidance to a range of $8.6 million to $30.6 million, as well as authorizing a $250 million share repurchase program. See our latest analysis for RLJ Lodging Trust. RLJ Lodging Trust's recent guidance upgrade and new buyback have arrived alongside a 22.75% 1 month share price return and a 33.61% 1 year total shareholder return, suggesting...
NYSE:PH
NYSE:PHMachinery

Parker-Hannifin (PH) Valuation Check After 11% Slide On Earnings And Raised Guidance

Earnings, guidance and a sharp pullback in Parker-Hannifin stock Parker-Hannifin (PH) is back in focus after a six day losing streak cut the stock by 11%, wiping about US$13b from its market value following earnings, raised guidance and a buyback update. See our latest analysis for Parker-Hannifin. The recent 11% slide and 1 day share price return of negative 1.75% sit in contrast to Parker Hannifin's 1 year total shareholder return of 39.84%. Short term momentum is fading even as long term...